ALVOAlvotech

NASDAQ · Biological Products, (No Diagnostic Substances)

Last close $5.80 · 2026-09-30

ABOUT

ExchangeNASDAQ

SectorHealthcare

IndustryBiological Products, (No Diagnostic Substances)

INSTITUTIONAL OWNERSHIP

Institutional holders74

Shares held47,219,625

Value$174.23M

Percent of shares outstanding15.13%

As of quarter end2026-06-30

RECENT NEWS

Alvotech taps LOTTE Biologics to support growing biosimilar portfolio
Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply
Alvotech stock surges after FDA manufacturing approval
FDA approves additional U
FDA approves additional U

CatalystPit

2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS